Back to Search VC Home Page
Venture Capital Search Engine
search over 1,000 Venture Capital related sites
Keywords about VC:  

Oxford Bioscience Partners

1.about LTI   (96%):
OUTSIDE DIRECTORS LTI has benefited from the advice and insight of a highly experienced group of outside directors. John M. Randolph. Director Currently active as a financial consultant and private investor. Was a founder and CEO of Randolph Computer Corporation. Cornelius T. Ryan, Director A found...
2.Easton Capital Investment Group::Targacept   (88%):
Targacept Targacept is an R&D pharmaceutical company formed as a spinout from RJ Reynolds Tobacco Company (NYSE: RJR) in August 2000. Targacept is involved with the development and commercialization of drugs based on selective activation of a previously unexploited class of targets - neuronal ni...
3.Arcturus Capital | Stevan Birnbaum   (87%):
Steve Birnbaum is a General Partner of Arcturus Capital and serves as the Chairman of the Investments Committee. Mr. Birnbaum has more than thirty years experience as a venture capitalist. He has led or made investments in more than 60 companies and has served as a general partner or equivalent of s...
4.Welcome to Academy Funds   (71%):
Academy Funds (Academy Ventures) is a family of venture capital funds focused on achieving outstanding investment returns in seed and early-stage companies. The following is a partial list of companies/institutions that have co-invested in and/or partnered with Academy portfolio companies: Advent V...
5.InterWest Partners - Investing in Information Technology & Life Sciences   (68%):
InterWest News InterWest Releases Portfolio News Portfolio Releases Events Portfolio Releases [ Portfolio Releases - Main ] Applied Spine Technologies Completes $15 Million Series B Round of Financing New investors include InterWest Partners and De Novo Ventures, joining Series A investors Oxford Bi...
6.Arboretum Ventures: Portfolio   (54%):
Asterand, Inc operates one of the world s largest tissue banks for genomic and proteomic research. Co-Investors: Oxford Bioscience Partners, Fort Washington Capital Partners, Chrysalis Ventures, Apjohn Ventures CardioMEMS, Inc. is creating innovative devices for the diagnosis, treatment and managem...
7.Venture capital alliances - syndicate firms from ARCH Venture Partners   (52%):
ARCH works with many other venture capital firms and institutional investors who serve as limited partners, co-investors, and sources of feedback for new company ideas. The following is a partial list of companies that have co-invested in ARCH portfolio companies as part of a syndicate. 3M Corporati...
8.Advertising Benefits   (51%):
Advertising with Dow Jones click on specific information at right You Are the Company We Keep As hundreds of companies have discovered, advertising in Private Equity Analyst newsletters, and sponsoring our events and reports, keeps you visible among influential decision-makers. In fact, you'll be in...
9.Grove Street Advisors - Our Team: Frank Angella - Principal   (51%):
10 years international experience in biotechnology venture capital and start-up operations Strong expertise and relationships in healthcare venture capital and European funds Prior Experience: Prior to joining GSA in 2001, Frank was a co-founder and Vice President of Biocode, a venture-backed spin-o...
10.Connecture: Interactive Sales Automation Solutions for Insurance   (50%):
Mission Statement & Message from CEO / Management / Board of Directors / News / Clients / Partners News Oxford Health Plans Launches New IDEA to Manage Renewals; Connecture Providing Web-Based Sales Automation Tools; New System Simplifies Renewal Process Trumbull, Connecticut (Dec. 12, 2002) Oxford ...
11.Connecture: Interactive Sales Automation Solutions for Insurance   (48%):
Mission Statement & Message from CEO / Management / Board of Directors / News / Clients / Partners News Oxford Expands IDEA Management System TRUMBULL, CONN. (August 19, 2003) Oxford Health Plans, Inc. (NYSE: OHP) announced today that it has expanded the functionality of its IDEA (Interactive Distri...
12.Flagship Ventures   (47%):
Flagship & Portfolio Company News Archives 2003 2002 Genstruct Appoints Dr. Michael Pavia to Its Board of Directors CAMBRIDGE, Mass., Feb. 14 /PRNewswire/ -- Genstruct, Inc., a knowledge-driven discovery company using systems biology to discover biomarkers to increase the effectiveness of drug disco...
13.Flagship Ventures   (46%):
Flagship & Portfolio Company News Archives 2003 2002 GENPATH PHARMACEUTICALS BECOMES AVEO PHARMACEUTICALS Cambridge, MA, March 1, 2005 GenPath Pharmaceuticals, Inc., a drug discovery and development company focused on the treatment of cancer and other diseases, announced today that it has changed it...
14.KBL Healthcare Ventures - Lumenos Launches Enlightened Approach to Health Care   (46%):
Back to News KBL in the News AVALON CLOSES $70 MILLION IN SERIES B FINANCING Company to Use Proceeds to Advance Next-Generation Genomic Drug Discovery Gaithersburg, MD, December 17, 2001 Avalon Pharmaceuticals today announced the close to new investors of a $70 million private equity financing throu...
15.KBL Healthcare Ventures - Lumenos Launches Enlightened Approach to Health Care   (46%):
Back to News KBL in the News AVALON CLOSES $70 MILLION IN SERIES B FINANCING Company to Use Proceeds to Advance Next-Generation Genomic Drug Discovery Gaithersburg, MD, December 17, 2001 Avalon Pharmaceuticals today announced the close to new investors of a $70 million private equity financing throu...
16.Harris & Harris Group Inc.   (45%):
PRESS RELEASE HARRIS & HARRIS GROUP, INC. FEBRUARY 1, 2005 111 WEST 57TH STREET NEW YORK, NEW YORK 10019 NASDAQ/NMS SYMBOL: TINY CONTACT: CHARLES E. HARRIS TEL. NO. (212) 582-0900 HARRIS & HARRIS GROUP INVESTS IN CAMBRIOS TECHNOLOGIES CORPORATION Harris & Harris Group, Inc. announced today that ...
17.CapitalVenue Massachusetts   (45%):
Venture Investors that have worked with CapitalVenue Home | Events | TeamVenue | Programs | "New" Newsletter | Contact us The following list of venture investors have participated in CapitalVenue's Past Events Adams Harkness and Hill Ventures Advanced Technology Program, NIST Advent Intern...
18.Granite Global   (44%):
HEALTHCARE Guava Technologies provides Personal Cell Analysis (PCA) products that have broad applications in life science cell biology research & development . Unlike the matur ed market for gene-based products, the cell analysis market is still in the early stage of growth. Similar to the Apple...
19.Connecture: Interactive Sales Automation Solutions for Insurance   (43%):
Client Success Metrics / Client Case Studies / Articles of Interest Oxford Health Plans Achieves Continued Broker Satisfaction and Adoption with the Addition of Small Group Quoting and Enrollment Automation As a leader in the health insurance industry, Oxford Health Plans has paved the way in innova...
20.BCM Technologies : News & Events   (43%):
News & Events Archive: 10/03/2005 PharmaFrontiers Presents Positive Tovaxin(TM) Research at International Multiple Sclerosis Meeting 08/10/2005 PharmaFrontiers to Present Tovaxin(TM) Research at International Multiple Sclerosis Meeting 07/25/2005 BCM Technologies president named to board of bioscie...

Page: 1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20  

VC Directory: A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z   Others